<p>MDA-MB-231, MDA-MB-468, BT-549, MCF-7 cells were transfected with three different siRNA oligonucleotides targeting CLDND1 or with a control siRNA for 72 h (A-H). Cells were then either subjected to Annexin V-APC staining and flow cytometry analysis (A-D) or analyzed for mRNA expression of CLDND1 with real-time quantitative PCR (E-H). Data in A-D (mean ± S.E.M., n = 3) represent percent AnnexinV-positive cells related to control conditions and in E-F (mean ± S.E.M., n = 2–3) represent CLDND1 mRNA levels normalized to control. Asterisks indicate statistically significant differences (*, p<0.05; **, p<0.01; ***, p<0.001) compared with control cells.</p
<p>(A) Expression of CHD1L protein in MDA-MB-231 cells (MDA231), MDA-MB-231 cells transfected with c...
INTRODUCTION: Triple-negative breast cancer (TNBC) is a heterogeneous disease with no definitive pro...
<p>(A) The CLPTM1L mRNA level after RNAi treatment was measured using quantitative real-time PCR in ...
<p>(A) mRNA expression of CLDND1 in various breast cancer cell lines. MDA-MB-231, MDA-MB-468, BT-549...
<p>MDA-MB-231 (A), MDA-MB-468 (B) and BT-549 (C) breast cancer cells were transfected with siRNA oli...
Identification of targets for apoptosis induction is important to provide novel therapeutic approach...
Identification of targets for apoptosis induction is important to provide novel therapeutic approach...
BACKGROUND:The claudin 1 tight junction protein, solely responsible for the barrier function of epit...
Claudin 6 (CLDN6) was found to be a breast cancer suppressor gene, which is lowly expressed in breas...
Human claudin-1 is an integral protein component of tight junctions, a structure controlling cell-to...
<p>A: cluster analysis and heat map of claudin 1 methylation (top), histogram of claudin 1 mRNA expr...
Triple-negative breast cancer (TNBC) is a heterogeneous disease with no definitive prognostic marker...
Breast cancer has a high incidence and mortality rate worldwide. Several viral vectors including len...
Abstract Background Claudin-6 (CLDN6), a member of CLDN family and a key component of tight junction...
<p>(<b>A</b>) PC3 cells were transfected with control siRNA (Ctrl) or ClpX- or ClpP-directed siRNA a...
<p>(A) Expression of CHD1L protein in MDA-MB-231 cells (MDA231), MDA-MB-231 cells transfected with c...
INTRODUCTION: Triple-negative breast cancer (TNBC) is a heterogeneous disease with no definitive pro...
<p>(A) The CLPTM1L mRNA level after RNAi treatment was measured using quantitative real-time PCR in ...
<p>(A) mRNA expression of CLDND1 in various breast cancer cell lines. MDA-MB-231, MDA-MB-468, BT-549...
<p>MDA-MB-231 (A), MDA-MB-468 (B) and BT-549 (C) breast cancer cells were transfected with siRNA oli...
Identification of targets for apoptosis induction is important to provide novel therapeutic approach...
Identification of targets for apoptosis induction is important to provide novel therapeutic approach...
BACKGROUND:The claudin 1 tight junction protein, solely responsible for the barrier function of epit...
Claudin 6 (CLDN6) was found to be a breast cancer suppressor gene, which is lowly expressed in breas...
Human claudin-1 is an integral protein component of tight junctions, a structure controlling cell-to...
<p>A: cluster analysis and heat map of claudin 1 methylation (top), histogram of claudin 1 mRNA expr...
Triple-negative breast cancer (TNBC) is a heterogeneous disease with no definitive prognostic marker...
Breast cancer has a high incidence and mortality rate worldwide. Several viral vectors including len...
Abstract Background Claudin-6 (CLDN6), a member of CLDN family and a key component of tight junction...
<p>(<b>A</b>) PC3 cells were transfected with control siRNA (Ctrl) or ClpX- or ClpP-directed siRNA a...
<p>(A) Expression of CHD1L protein in MDA-MB-231 cells (MDA231), MDA-MB-231 cells transfected with c...
INTRODUCTION: Triple-negative breast cancer (TNBC) is a heterogeneous disease with no definitive pro...
<p>(A) The CLPTM1L mRNA level after RNAi treatment was measured using quantitative real-time PCR in ...